BiotechTube
Home/Bcal Diagnostics/Alexandra Feetham
AF

Alexandra Feetham

Head of Innovation

Bcal Diagnostics

Therapeutic Areas

Oncology

Bcal Diagnostics Pipeline

DrugIndicationPhase
BREASTEST plus™Breast cancer screeningCommercial
Avantect® Pancreatic Cancer TestPancreatic cancer early detectionCommercial
Avantect® Ovarian Cancer TestOvarian cancer early detectionCommercial

Leadership Team at Bcal Diagnostics

SR
Shane Ryan
Chief Executive Officer
GR
Guy Robertson
Chief Financial Officer & Company Secretary
JS
Jayne Shaw
Co-Founder and Executive Chair
View full Bcal Diagnostics profile